STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Clinical trials for STAGE IIIC CUTANEOUS MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC CUTANEOUS MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC CUTANEOUS MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise against tough skin cancer
Disease control CompletedThis study tested whether adding bevacizumab to ipilimumab helps people with advanced melanoma that cannot be removed by surgery. 169 participants received either ipilimumab alone or with bevacizumab. The goal was to see if the combination improved overall survival and slowed can…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New combo therapy shows promise for tough melanoma
Disease control CompletedThis small early-phase study tested whether combining a topical skin cream (imiquimod) with an immunotherapy drug (pembrolizumab) is safe and effective for people with advanced melanoma that has spread. Seven participants with stage IIIB-IV melanoma were enrolled. The goal was to…
Matched conditions: STAGE IIIC CUTANEOUS MELANOMA AJCC V7
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:03 UTC